Longeveron vs China SXT Pharmaceuticals
LGVN and SXTC side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How LGVN and SXTC compare
China SXT Pharmaceuticals grew revenue faster over the last twelve months (−34.6% versus −42.7% for Longeveron).
China SXT Pharmaceuticals keeps more of each dollar of sales as profit, with a net margin of −545% compared with −1978% at Longeveron.
Longeveron scores higher on the StockData Score (5 against 4 for China SXT Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | LGVN | SXTC |
|---|---|---|
| Size and price | ||
| Market cap | $67.3M | – |
| Share price | $2.11 | $2.86 |
| Change, 1 year | −69.0% | −100.0% |
| Change, 5 years | −99.9% | −100% |
| Beta (5Y) | 1.44 | – |
| Employees | 37 | 56 |
| StockData Score | ||
| Total score | 5 (better) | 4 |
| Valuation score | 0 | 0 |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 5 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 56.7× | – |
| P/B | 6.5× | – |
| FCF yield | −30.5% | – |
| Growth | ||
| Revenue growth (TTM) | −42.7% | −34.6% (better) |
| Revenue growth, 5Y average | −26.6% | −24.9% (better) |
| Profitability | ||
| Gross margin | 69.8% (better) | 21.9% |
| Operating margin | −1993% | −626% (better) |
| Net margin | −1978% | −545% (better) |
| FCF margin | −1730% | – |
| Return on equity | −204% | −27.5% (better) |
| Return on invested capital | −1412% (better) | −1657% |
| Financial health | ||
| Debt / equity | 0.00 | 0.03 (better) |
| Interest coverage | – | −113.1× |
| Current ratio | 2.63 | 7.93 (better) |
| Altman Z-score | −9.42 | – |
| Piotroski F-score | 1 | 3 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 1.5% | – |
| Held by insiders | 43.8% | 0.00% |
| Short interest, % of float | 0.88% | 2.9% |
Go deeper
- LGVN stock overview
- LGVN income statement
- LGVN valuation and score
- SXTC stock overview
- SXTC income statement
- SXTC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.